|
1
|
Identification of circulating microRNA signatures for breast cancer detection.
|
Clin Cancer Res
|
2013
|
1.67
|
|
2
|
Diagnostic issues in second opinion consultations in prostate pathology.
|
Pathology
|
2010
|
1.42
|
|
3
|
Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins.
|
J Clin Pathol
|
2011
|
1.38
|
|
4
|
Hormone receptor and c-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance.
|
Am J Clin Pathol
|
2010
|
1.29
|
|
5
|
Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.
|
Breast
|
2010
|
1.04
|
|
6
|
p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6.
|
Nucleic Acids Res
|
2012
|
0.99
|
|
7
|
DEAD-box helicase DP103 defines metastatic potential of human breast cancers.
|
J Clin Invest
|
2014
|
0.97
|
|
8
|
TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).
|
Clin Cancer Res
|
2012
|
0.95
|
|
9
|
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
|
Mod Pathol
|
2010
|
0.94
|
|
10
|
Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer.
|
Histopathology
|
2012
|
0.94
|
|
11
|
Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms.
|
Histopathology
|
2010
|
0.93
|
|
12
|
Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
|
Int J Oncol
|
2010
|
0.87
|
|
13
|
Mucin extravasation in breast core biopsies--clinical significance and outcome correlation.
|
Histopathology
|
2009
|
0.87
|
|
14
|
Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer.
|
Breast Cancer Res Treat
|
2015
|
0.86
|
|
15
|
HER2/neu revisited: quality and interpretive issues.
|
J Clin Pathol
|
2010
|
0.84
|
|
16
|
Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancer.
|
Histopathology
|
2014
|
0.84
|
|
17
|
Implications of the Updated 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 Gene Testing Using Immunohistochemistry and Fluorescence In Situ Hybridization for Breast Cancer.
|
Arch Pathol Lab Med
|
2016
|
0.81
|
|
18
|
Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram.
|
J Clin Pathol
|
2013
|
0.81
|
|
19
|
Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome.
|
Histopathology
|
2013
|
0.80
|
|
20
|
Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups.
|
Breast Cancer Res Treat
|
2014
|
0.80
|
|
21
|
Histiocytoid breast carcinoma: an enigmatic lobular entity.
|
J Clin Pathol
|
2011
|
0.80
|
|
22
|
Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression.
|
Breast Cancer Res Treat
|
2010
|
0.79
|
|
23
|
Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions.
|
J Clin Pathol
|
2012
|
0.79
|
|
24
|
Role of epithelial-mesenchymal transition markers in triple-negative breast cancer.
|
Breast Cancer Res Treat
|
2015
|
0.79
|
|
25
|
Sentinel lymph nodes with isolated tumour cells and micrometastases in breast cancer: clinical relevance and prognostic significance.
|
J Clin Pathol
|
2013
|
0.78
|
|
26
|
Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients.
|
Breast Cancer Res Treat
|
2015
|
0.77
|
|
27
|
Clinicopathologic Characteristics of Solid Papillary Carcinoma of the Breast.
|
Am J Surg Pathol
|
2016
|
0.76
|
|
28
|
Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast.
|
Breast Cancer Res Treat
|
2015
|
0.76
|
|
29
|
Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.
|
Breast Cancer Res Treat
|
2015
|
0.76
|
|
30
|
Immunohistochemical expression of homeoproteins Six1 and Pax3 in breast phyllodes tumours correlates with histological grade and clinical outcome.
|
Histopathology
|
2014
|
0.76
|
|
31
|
Expression of heparan sulfate in gastric carcinoma and its correlation with clinicopathological features and patient survival.
|
J Clin Pathol
|
2010
|
0.76
|
|
32
|
Intranuclear inclusions in epithelial cells of benign proliferative breast lesions.
|
J Clin Pathol
|
2011
|
0.76
|
|
33
|
Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: novel markers in biological classification.
|
Breast Cancer Res Treat
|
2011
|
0.76
|
|
34
|
Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival.
|
Singapore Med J
|
2014
|
0.75
|